Eamonn Hobbs Joins Marvao Medical Board of Directors
Medical Technology Industry Leader Will Serve as Chairman
GALWAY, Ireland -- March 3, 2014
Marvao Medical Devices Limited today announces that medical technology
industry leader Eamonn P. Hobbs has been appointed Chairman of the Company’s
Board of Directors. Mr Hobbs replaces former Board Chairman John Burns, who
will continue to serve as a member of the Board.
“Eamonn Hobbs is both an industry thought leader and a proven builder of
successful organizations,” said Chris Davey, Co-Founder and CEO of Marvao. “He
brings to Marvao a wealth of clinical, regulatory, operational and commercial
contacts and leadership experiences which will benefit both our Board as well
as our entire company. We look forward to working with him as Marvao further
develops its NexSite™ product line.” Mr Davey continued, “In welcoming Eamonn,
our Board would also like to thank John Burns for his outstanding leadership
as our chairman over the last five years, and we look forward to his continued
dedicated service as a Marvao director moving forward.”
“Marvao has reached an inflection point in its corporate development, and the
invitation to join the Board of Directors and serve as chairman was quite
compelling,” said Mr Hobbs. “The company’s recent FDA clearance for a dialysis
catheter product line utilizing Marvao’s NexSite™ technology is an important
milestone from which the Company can commence commercialization and develop
additional NexSite product lines.”
A dual citizen of Ireland and the United States, Mr Hobbs brings to Marvao
more than 30 years of leadership experience in a number of medical technology
industry segments including interventional radiology, oncology, interventional
cardiology, surgery, gastroenterology and medical device/pharmaceutical
combination products. After graduating from the University of
Massachusetts-Lowell in 1980 with a degree in Plastics Engineering, Mr Hobbs
immediately went to work as a Product Development Engineer with Cook
Incorporated. He co-founded AngioDynamics in 1988 and served as the Company’s
President and CEO until 2008. During his tenure, he built the Company into a
global market leader with more than $200 million in sales and 700 employees.
In 2009 he transitioned from a Delcath Systems, Inc. Board of Directors member
to President and CEO and served as Chairman on the Medical Device
Manufacturers Association (MDMA) Board of Directors from 2010 to 2013.
In addition to Marvao, Mr Hobbs also is Chairman of the Board of Morris
Innovative, Inc., and is a member of the Board of Directors of Antares
Pharmaceuticals (NASDAQ: ATRS); Harmonic Medical, Inc. the MDMA and the Glens
Falls (NY) Hospital.
About NexSite™ ESM^TM
Many types of catheters exit the patient’s body through an open wound in the
skin. Effective management of the catheter exit site using antibiotic
ointments or antimicrobial dressings has been shown to reduce the risk of
catheter related bloodstream infection (CRBSI) associated with these
catheters. Marvao Medical’s innovative NexSite™ ESM™ technology is a novel
technology for the management of the catheter exit site. It is based on tissue
ingrowth and features our patented DISC™ (Dermal Ingrowth Support Collar) that
enables the wound in the skin at the catheter exit site to heal. Marvao
Medical is working to incorporate NexSite™ ESM™ technology on a broad range of
long term implantable medical devices.
About Marvao Medical
Marvao Medical specializes in the development, manufacturing and marketing of
innovative medical devices to address unmet clinical needs and deliver high
quality of care to the patient population.
Based at the Innovation in Business Centre on the Galway Mayo Institute of
Technology campus, Marvao Medical is supported by investments from Enterprise
Ireland, the Western Development Commission, Enterprise Equity and private
investors. Marvao Medical has partnered with Harmac Medical Products
(Castlerea, Roscommon) to manufacture NexSite catheter products.
More information can be obtained at www.marvaomedical.com.
Contact person: Jonathan Bouchier-Hayes, Director of Business Development
Phone: +353 87 325 9728
Press spacebar to pause and continue. Press esc to stop.